Effect of silymarin on the liver and pain of rheumatoid arthritis patients

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2020
INTERVENTION: Intervention 1: Intervention group: Take daily with oral 280‐mg Silymarin ?For 2 months. Intervention 2: Control group: Control group take under the administration of placebo. CONDITION: Rheumatoid arthritis. ; Rheumatoid arthritis with rheumatoid factor PRIMARY OUTCOME: ???. Timepoint: Before and 60 Day after intervention. Method of measurement: Visual Analogue Scale. Hepatotoxicity. Timepoint: Before and 60 Day after intervention. Method of measurement: check list. INCLUSION CRITERIA: Age between 16 and 85 No history of liver disease taking methotrexate Diagnosis of rheumatoid arthritis with criteria American Collage of Rhematology
Epistemonikos ID: c5621d3aee1b42158dfd543de201c56b14279744
First added on: Mar 23, 2022